Table 1. Clinic and Demographic Characteristic of Patientsa,b.
Variables | Sarcoidosis | NS ILD | P Value |
---|---|---|---|
No of subjects | 119 | 142 | - |
Age, y | 47.58 ± 12.2 | 56.8 ± 13.3 | 0.000 |
Gender, Male c | 32 (26.9) | 77 (54.2) | 0.000 |
Smoking status (% of subjects) c/n/e | 12/68/20 | 18/48/34 | 0.020 |
Smoking pack-year | 11.8 ± 9.8 | 25.5 ± 14.4 | 0.000 |
ESR mm/h | 23 (3 - 83) | 33 (3 - 85) | 0.866 |
CRP mg/dL | 4.6 (2 - 120) | 14 (2 - 179) | 0.039 |
FEV1 % pred. | 95 (41 - 136) | 88 (21 - 140) | 0.038 |
FVC % pred. | 98 (42 - 140) | 83 (0 - 137) | 0.001 |
DLCO % pred | 79 (29 - 119) | 63 (22 - 113) | 0.001 |
Pulmonary function test (% of subjects) | 0.001 | ||
DLCO ≥ 80% pred | 50 | 33 | |
DLCO 60 - 79 % pred | 30 | 28 | |
DLCO 40 - 59 %pred | 17 | 22 | |
DLCO ≤ 40 % pred | 3 | 17 | |
Spirometric results (% of subjects) | 0.003 | ||
Normal | 77 | 44 | |
Restrictive | 19 | 49 | |
Obstructive | 4 | 7 |
aValues presented as mean ± SD, or median (min-max).
babbreviations: c = current smoker, n: never smoked, CRP: C-reactive protein, DLCO: Diffusion capacity of lung for carbonmonoxide, Smoking status, e: exsmoker. ESR: Erytrocyte sedimantation rate, FEV1: Forced expiratory volume in first second. FVC: Forced vital capacity.
cValues are presented as No. (%).